Currently, the CCP2 test, which is based on a synthetic citrullinated peptide not related to proteins occurring in the inflamed joints of RA patients, is the gold standard [27-29] for ACPA testing. The gene discussed is PRTN3; the disease is rheumatoid arthritis.